You’re about to embark on a journey of discovery. And like all journeys that are worthwhile, it’s far from linear. The process of antibody discovery and development into a clinical candidate is one full of twists, turns, roundabouts and offshoots, yet one that an increasing number of researchers and companies, both small and large, have successfully navigated.
